SCHEMBL10273708

SCHEMBL10273708

COC(=O)Cc1cc(NS(C)(=O)=O)ccc1-c1cnccc1C

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 18/20 0.65
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526764 0.83 CYP17A1 (0.69) CYP17A1PTGS1PTGS2
SCHEMBL18036554 0.80 CYP17A1 (0.65) CYP17A1PTGS1PTGS2
SCHEMBL10272847 0.80 CYP17A1 (0.41) CYP17A1
SCHEMBL526869 0.80 CYP17A1 (0.70) CYP17A1PTGS1PTGS2
SCHEMBL526391 0.79 CYP17A1 (0.78) CYP17A1PTGS1PTGS2
SCHEMBL527331 0.79 CYP17A1 (1.00) CYP17A1
SCHEMBL10272852 0.79 PDGFRB (0.43) CYP17A1
SCHEMBL526755 0.76 CYP17A1 (0.76) CYP17A1PTGS1PTGS2
SCHEMBL526951 0.76 CYP17A1 (0.76) CYP17A1
SCHEMBL526580 0.74 CYP17A1 (0.76) CYP17A1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012015723-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-02 WO disclosed